Recombinant multi-species APRIL/TNFSF13/CD256 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APRIL/TNFSF13/CD256 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of this gene have been identified; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
The Alternative Names of target: 2310026N09Rik,A proliferation-inducing ligand (APRIL),APRIL,April,CD256,TALL-2,TALL2,TNF- and APOL-related leukocyte expressed ligand 2 (TALL-2),TNF-related death ligand 1 (TRDL-1),TNFSF13,TNLG7B,TRDL-1,Tall2,Tnfsf13,Tnlg7b,Trdl1,Tumor necrosis factor ligand superfamily member 13,UNQ383/PRO715,ZTNF2
Go
to APRIL/TNFSF13/CD256 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T14676-Ag-1/ GM-Tg-hg-T14676-Ag-2 | Human APRIL/TNFSF13/CD256 protein | Human |
| GM-Tg-rg-T14676-Ag-1/ GM-Tg-rg-T14676-Ag-2 | Rat APRIL/TNFSF13/CD256 protein | Rat |
| GM-Tg-mg-T14676-Ag-1/ GM-Tg-mg-T14676-Ag-2 | Mouse APRIL/TNFSF13/CD256 protein | Mouse |
| GM-Tg-cynog-T14676-Ag-1/ GM-Tg-cynog-T14676-Ag-2 | Cynomolgus/Rhesus macaque APRIL/TNFSF13/CD256 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T14676-Ag-1/ GM-Tg-felg-T14676-Ag-2 | Feline APRIL/TNFSF13/CD256 protein | Feline |
| GM-Tg-cang-T14676-Ag-1/ GM-Tg-cang-T14676-Ag-2 | Canine APRIL/TNFSF13/CD256 protein | Canine |
| GM-Tg-bovg-T14676-Ag-1/ GM-Tg-bovg-T14676-Ag-2 | Bovine APRIL/TNFSF13/CD256 protein | Bovine |
| GM-Tg-equg-T14676-Ag-1/ GM-Tg-equg-T14676-Ag-2 | Equine APRIL/TNFSF13/CD256 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T14676-Ag-1/ GM-Tg-hg-T14676-Ag-2;
GM-Tg-rg-T14676-Ag-1/ GM-Tg-rg-T14676-Ag-2;
GM-Tg-mg-T14676-Ag-1/ GM-Tg-mg-T14676-Ag-2; GM-Tg-cynog-T14676-Ag-1/ GM-Tg-cynog-T14676-Ag-2; GM-Tg-felg-T14676-Ag-1/ GM-Tg-felg-T14676-Ag-2; GM-Tg-cang-T14676-Ag-1/ GM-Tg-cang-T14676-Ag-2; GM-Tg-bovg-T14676-Ag-1/ GM-Tg-bovg-T14676-Ag-2; GM-Tg-equg-T14676-Ag-1/ GM-Tg-equg-T14676-Ag-2 |
| Products Name | APRIL/TNFSF13/CD256 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | APRIL/TNFSF13/CD256 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APRIL/TNFSF13/CD256 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.